Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

PHASE2RecruitingINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

April 14, 2020

Primary Completion Date

July 6, 2026

Study Completion Date

January 6, 2031

Conditions
Grade 1 MeningiomaGrade 2 MeningiomaGrade 3 MeningiomaRecurrent MeningiomaUnresectable Meningioma
Interventions
RADIATION

Gallium Ga 68-DOTATATE

Given IV

DRUG

Lutetium Lu 177 Dotatate

Given IV

PROCEDURE

Magnetic Resonance Imaging

Undergo PET/MRI

PROCEDURE

Positron Emission Tomography

Undergo PET/MRI

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Computed Tomography

Undergo PET/CT and/or SPECT/CT

PROCEDURE

Biospecimen Collection

Undergo blood sample collection

PROCEDURE

Single Photon Emission Computed Tomography

Undergo SPECT/CT

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER